AKT1 and acute myeloid leukemia: Specifically, in vitro experiments confirm that IGF-I promotes the growth of AML cells primarily through the activation of the PI3K/Akt and ErK signaling pathways, a process that aligns with the fact that uncontrolled PI3K activation is present in 50% of AML cases (149, 150).